Ob jectives: Physicians com m only u se etom id ate for ad u lt rap id -sequ ence intu bation (RSI), bu t the m anu factu rer d oes not recom m end its u se for child ren u nd er 10 years of age d ue to a lack of d ata. The authors present their experience w ith etom id ate for p ed iatric RSI in ord er to fu rther d evelop its risk-benefit p rofile in this age grou p . Meth od s: Trained abstractors review ed the m ed ical record s for all child ren u nd er 10 years old w ho received etom id ate for RSI betw een Etom id ate for ad u lt RSI has now becom e both com m onp lace and accep ted by m ost em ergency physicians.
no cases of d ocumented myoclonus, status epilepticus, or new -onset seizu res. Thirty-eight p atients received corticosteroid s d u ring the hosp ital cou rse, none for su sp ected ad renal insu fficiency. Three p atients d ied , all from severe brain injury. Con clu sion s: In child ren less than 10 years old , etom id ate seem s to prod uce m inim al hem od ynam ic changes, and ap p ears to have a low risk of clinically imp ortant ad renal insu fficiency, m yoclonu s, and statu s ep ilep ticu s. The association betw een etom id ate and em esis (observed in less than 3% of enrolled p atients) rem ains unclear. For clinical situations in which minimal blood pressure changes d uring RSI are critical, etomid ate appears to have a favorable risk-benefit p rofile for child ren u nd er 10 years old . Key w ord s: ped iatrics; intubation; etomid ate; anesthetic; ad verse effects. ACADEMIC EMERGEN CY MEDICIN E 2003; 10:134-139.
Etom id ate w as ap p roved for u se in the United States in 1983 as an intravenou s hyp notic. Several d esirable p rop erties m ake it an attractive agent for rap idsequ ence intu bation (RSI). Rap id onset, 1 brevity of action, 2 lack of card iovascu lar d ep ression, 3 and protection of intracranial pressure 4 all contribute to its grow ing pop ularity am ong em ergency physicians. 5 However, researchers have also associated etomid ate with an increased likelihood of myoclonus, 6 ad renal su p p ression, 7, 8 em esis, 9 and possibly seizu res. 10 Etom id ate for ad u lt RSI has now becom e both com m onp lace and accep ted by m ost em ergency physicians. 11 H ow ever, few researchers have examined etom id ate for RSI in p ed iatric p atients, and ind eed , the m anu factu rer d oes not recom m end its u se in child ren u nd er 10 years old d u e to insu fficient d ata in this age grou p . 12 The cu rrent stu d y sou ght to exp and the available inform ation on the safety of etom id ate for RSI in p atients less than 10 years old . The objectives w ere threefold : first, to evalu ate the frequ ency of im m ed iate ad verse events associated w ith etom id ate u se for p ed iatric RSI, inclu d ing vom iting, seizu res, and m yoclonu s; second , to fu rther d ocu m ent the hem od ynam ic effects of etom id ate on child ren u nd er 10 years old ; and third , to assess for d elayed ad verse events, inclu d ing clinically recognized ad renocortical su p p ression and p ersistent or recu rrent seizu res.
METHODS
Stu d y D esign . Data w ere obtained through a stand ard ized retrospective chart review, with extensive efforts m ad e to abid e by p reviou sly p u blish ed strategies for im p roving the qu ality of chart review research. 13 The institu tional review board d eclared this stu d y exem p t from form al review and w aived the requ irem ent for inform ed consent. When I was a boy, I had an inquisitive mind. To every question an answer I strove hard to find. I found lots of them, all cherished and put aside.
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Today I look at the bunch: The varnish is peeling and you know what? There are more questions inside! and p ost-intu bation, and w ithin 10 m inu tes of receiving etom id ate. Seventy-five p atients had p re-and post-intubation heart rate d ocum ented . We compared those child ren w ho had com plete 
DISCUSSION
We review ed 105 cases of etom id ate-assisted RSI in child ren u nd er 10 years of age in an attem p t to better d efine the risks and benefits. We fou nd that, am ong the 52 p atients w ho had m u ltip le blood p ressu re m easu rem ents w ithin the d u ration of action of etom id ate, there w as no significant hem od ynam ic change. These resu lts p arallel those of Sokolove and colleagu es, w ho retrosp ectively exam ined 100 p atients u nd er the age of 10 and fou nd only a 1-m m H g d rop in blood p ressu re after etom id ate-ind u ced RSI. 15 Researchers have fou nd sim ilar resu lts w hen they u se etom id ate for child ren u nd ergoing general anesthesia for elective p roced u res, 16, 17 and for p roced u ral sed ation. 18 Tw o recent stu d ies review ed the effects of etom id ate for p roced u ral sed ation. The first fou nd that one in 38 child ren need ed a flu id bolu s for hyp otension, although concomitant ad ministration of op iates m akes these resu lts d ifficu lt to interp ret. 19 A second stu d y looked at 51 ep isod es of p roced u ral sed ation in a com bination of ad u lts and child ren and fou nd that the largest d rop in blood p ressu re w as in a 6-year-old girl w hose SBP d rop p ed from 155 to 107 mm H g. 20 Thu s, the available d ata su ggest that the m inim al hem od ynam ic effects of etom id ate, w ell d ocumented in ad ults, probably generalize to child ren u nd er 10 years old . While this suggests that the im portant ad vantage of etom id ate (the p reservation of blood p ressu re) persists in this age group, the d isad vantages are still u nclear. The best-d ocu m ented ad verse effect of etom id ate involves ad renal su p p ression, [21] [22] [23] which has been show n by laboratory stu d ies to occu r follow ing even a single bolu s d ose (althou gh the clinical im p lications of this are u nclear). Only tw o stu d ies have exam ined this issu e in you ng child ren. Both the cu rrent stu d y of 105 child ren and a sim ilar stu d y of 100 child ren fou nd no evid ence of clinically recognized ad renal suppression in this population. 15 Thu s, it ap p ears that the incid ence of clinically recognized ad renal su p p ression in you nger child ren, follow ing a single bolu s d ose of etom id ate for RSI in the ED, is less than 1 in 205 (0.5%, 95% CI ¼ 0% to 1.8%).
TABLE 1. Ad ve rse Events Oc c urring within 10 Minutes of Etom id a te Ad m inistra tion
Another potential d raw back to the use of etom id ate involves the p otential for im m ed iate com p lications su ch as m yoclonu s, seizu res, or em esis. The anesthesia literatu re contains several rep orts of m yoclonu s associated w ith etom id ate. [24] [25] [26] Only three reports from the ED setting have exam ined this issu e. The first p rosp ectively stu d ied 48 p atients, ten of w hich were child ren, who und erwent proced ural sed ation u sing etom id ate. The au thors fou nd fou r cases of myoclonus, one of w hich they d escribed as ''total bod y stiffness'' that lasted abou t 1 m inu te. 20 The second stu d y looked at 34 ad u lt p atients w ho received etom id ate for RSI, and these au thors rep ort one case of m yoclonus that d id not interfere w ith intu bation. 27 A third review looked at 18 adult ED patients intu bated w ith only etom id ate and fou nd a 70% incid ence of m yoclonu s. 28 Ou r rep ort of 105 p ed iatric RSIs fou nd no evid ence of m yoclonu s. Concu rrent u se of rap id -onset p aralytics certainly w ou ld m inim ize any m yoclonic m ovem ents. Practitioners w ho use paralytics w ith a slow er onset than succinylcholine may encounter myoclonus, but this w ould likely be clinically insignificant given the p harm acological p aralysis of RSI.
While p aralytics m ay cou nteract the p otential d ifficu lties of m yoclonu s, they m ay also p revent clinicians from recognizing ongoing seizu re activity. Variou s rep orts in the anesthesia literatu re have su ggested a p otential connection betw een etom id ate and seizures. 29, 30 Recently, Lau rin et al. com p ared etom id ate w ith the com bination of fentanyl and m id azolam for p roced u ral sed ation in the ED. They noted that tw o of the 42 ad u lts w ho received etom id ate had seizu res, com p ared w ith no p atient in the fentanyl/ m id azolam grou p . 31 In contrast, an ED stu d y of 51 cases of etom id ate-assisted p roced u ral sed ation fou nd no seizu re (althou gh the one case of ''total bod y stiffness'' d escribed above as m yoclonu s m ay have actu ally been a tonic seizu re). 20 Dickenson and Singer review ed the m ed ical record s of 38 child ren w ho received etom id ate in conju nction w ith op iates for ED p roced u ral sed ation and also fou nd no d ocumentation of seizures. 19 Our stu d y review ed not only the ED course, but also the rem aind er of the hosp ital cou rse, for evid ence of statu s ep ilep ticu s or recu rrent seizu res in child ren receiving etom id ate for RSI. Fou r child ren had a recu rrent seizu re at som e p oint d u ring their hosp italization after receiving etom id ate in the ED; all of them p resented to the ED with altered mental status second ary to a seizure and a known seizure disorder. No child developed status ep ilep ticu s. Althou gh the frequ ency of d ocu m ented seizu res in this stu d y ap p ears low, the tru e incid ence in p atients w ho are chem ically p aralyzed cou ld be d etermined only by concurrent electroencephalograp hy (EEG). H ow ever, u ntil fu rther stu d ies d eterm ine the d egree to w hich etom id ate low ers the seizure threshold (if it d oes so at all), it w ou ld seem p ru d ent to w eigh the risks and benefits of etom id ate in younger child ren presenting w ith a seizu re or know n seizu re d isord er. Ad d itionally, in p atients intu bated with etomid ate, physicians should consid er intermittently w ithhold ing su p p lem ental p aralytics, after the initial p aralysis of RSI, in ord er to clinically assess for ongoing seizu re activity.
In ad d ition to the rep orts of m yoclonu s and seizu re activity, researchers have linked etom id ate to an increased risk of vom iting. 9, 32 One recent d oubleblind stu d y com p ared p rop ofol w ith etom id ate for general anesthesia and fou nd that 26.8% of fem ale p atients vom ited after receiving etom id ate, com p ared w ith only 10% w ho received p rop ofol. 33 There have been m ixed results am ong ED stu d ies. For patients u nd ergoing p roced u ral sed ation w ith etom id ate, Dickenson and Singer fou nd no vom iting am ong 38 child ren, 19 while two other stud ies report incid ences of one in 42 31 and one in 48 sed ations. 20 One ou t-ofhosp ital stu d y review ed 44 cases of p atients intu bated in the field u sing only etom id ate (no p aralytics) and fou nd that eight vom ited after receiving the m ed ication. 34 Only one sm all stud y to d ate has ad d ressed this issue in patients und ergoing RSI in the ED, and the researchers rep orted no vom iting am ong 34 intu bations. 27 Ou r investigation fou nd that three of 105 p atients vom ited w ithin 10 m inu tes of receiving etom id ate, one p rior to being intu bated . Med ication effects often vary based on the age of the child , w ith infants and tod d lers reacting d ifferently than old er child ren. While the m ost frequ ent age of p atients in ou r stu d y w as betw een 91 d ays and 2 years, the absolute num ber of patients in these age ranges is sm all, m aking generalization to this popu lation d ifficu lt. Finally, the d ose of etom id ate w as not stand ard ized , resu lting in a broad range of d oses that w eakens the strength of ou r conclu sions. Id eally, a prospective randomized blinded study comparing etom id ate w ith other ind u ction agents w ou ld solve m any of these lim itations and yield the m ost u sefu l inform ation.
CONCLUSIONS
This stu d y d escribes ou r ED exp erience w ith 105 child ren u nd er 10 years of age w ho u nd erw ent RSI u sing etom id ate. Etom id ate offers a very low risk of clinically recognized ad renal su p p ression, and a low risk of seizu res. The risk of em esis rem ains uncertain. For child ren w ho had blood p ressu re d ocu m ented both before etom id ate and w ithin 10 m inu tes of its ad m inistration (52 of 105), there w as no significant change noted . Althou gh the m anu factu rer has not yet recomm end ed etom id ate for child ren in this age range, the available d ata su ggest that for p atients w ho need hem od ynam ic stability d u ring RSI, etom id ate has a favorable risk-benefit p rofile. For clinical situ ations that d o not requ ire the hem od ynam ic stability of etom id ate, the risk-benefit p rofile is less clear.
